Haider S A, Hassett P, Bron A J
Institute of Ophthalmology, Mayo Hospital, Lahore, Pakistan.
Retina. 2001;21(3):210-3. doi: 10.1097/00006982-200106000-00002.
Intravitreal antibiotics are the mainstay of treatment of endophthalmitis following cataract surgery. The purpose of this study is to determine the range of intraocular vancomycin found after intravitreal therapy and assess the optimum time for repeat injections.
Aqueous and vitreous vancomycin was assayed at the time of reinjection in 14 patients with endophthalmitis showing a poor clinical response after their primary injection. Nine patients received vancomycin 2 mg and another five received vancomycin 1 mg. In six patients the injection was repeated at 48 hours and in seven at 72 hours. Two patients received three injections.
Aqueous vancomycin varied from 8.4 to 170 mg/L and the vitreous vancomycin level ranged from 21.2 to 220 mg/L.
In the current study vitreous vancomycin levels were variable, but well within the therapeutic range for sensitive Gram-positive organisms. At times they exceeded the putative retinotoxic levels (100 mg/L). Higher aqueous levels were found after an injection of 2 mg than after 1 mg. Vancomycin levels were still very high 3 days after injection of 2 mg where results were available. Assay at the time of repeat injection may provide insight into the adequacy of vitreous levels and guide future therapy.
玻璃体内注射抗生素是白内障手术后眼内炎治疗的主要手段。本研究的目的是确定玻璃体内注射治疗后眼内万古霉素的浓度范围,并评估重复注射的最佳时间。
对14例初次注射后临床反应不佳的眼内炎患者在再次注射时测定房水和玻璃体内的万古霉素含量。9例患者接受2mg万古霉素注射,另外5例接受1mg万古霉素注射。6例患者在48小时时重复注射,7例在72小时时重复注射。2例患者接受了三次注射。
房水万古霉素浓度在8.4至170mg/L之间,玻璃体内万古霉素浓度在21.2至220mg/L之间。
在本研究中,玻璃体内万古霉素浓度各不相同,但均在敏感革兰氏阳性菌的治疗范围内。有时它们超过了假定的视网膜毒性水平(100mg/L)。注射2mg后房水浓度高于注射1mg后。在有结果的情况下,注射2mg后3天万古霉素浓度仍然很高。再次注射时进行检测可有助于了解玻璃体内药物浓度是否足够,并指导未来的治疗。